The Biotech Index is up 205% since Jan 2009, after FIVE CONSECUTIVE annual gains of 15%, 14%, 13%, 15%, then 69% last year, as well as 12% so far in 2014

The Biotech Index is up 205% since Jan 2009, after FIVE CONSECUTIVE annual gains of 15%, 14%, 13%, 15%, then 69% last year, as well as 12% so far in 2014. The chart is spectacular: (VIEW LINK), and surely has only so much longer to run in this perpendicular ascent? Life science analysts make a good case for why it still has legs, but caution still seems wise. Barrons wrote: While the fundamentals are better than the S&P500, we anticipate that generalists will move away from biotech to other sectors when the macro environment improves. Until then, large-cap biotech will continue to post solid gains, but even large cap valuations are getting stretched. The upshot: We expect further consolidation and volatility but looks like the sector has another leg up, Werber says. [Be] cognizant that valuation is rich already so watch for signs of continued sell off. (VIEW LINK)


MORE ON



The Livewire Equities feed brings you a range of insights that relate to Australian equities

Expertise

No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.